Gene · 5696
Papers2,476
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,476
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systematic genetic analysis of pediatric patients with autoinflammatory diseases. | Front Genet | 2023 | 36777733 | PubTator, text mining | PubMed |
| Identification of platinum resistance-related gene signature for prognosis and immune analysis in bladder cancer. | Front Genet | 2023 | 36777726 | PubTator, text mining | PubMed |
| Identification of potential biomarkers and immune infiltration characteristics in recurrent implantation failure using bioinformatics analysis. | Front Immunol | 2023 | 36776897 | PubTator, text mining | PubMed |
| A New Signature of Sarcoma Based on the Tumor Microenvironment Benefits Prognostic Prediction. | Int J Mol Sci | 2023 | 36769292 | PubTator, text mining | PubMed |
| Dysregulation of Gene Expression of Key Signaling Mediators in PBMCs from People with Type 2 Diabetes Mellitus. | Int J Mol Sci | 2023 | 36769056 | PubTator, text mining | PubMed |
| Myelin Basic Protein Fragmentation by Engineered Human Proteasomes with Different Catalytic Phenotypes Revealed Direct Peptide Ligands of MS-Associated and Protective HLA Class I Molecules. | Int J Mol Sci | 2023 | 36768413 | PubTator, text mining | PubMed |
| Transcriptomic and Functional Evidence That miRNA193a-3p Inhibits Lymphatic Endothelial Cell (LEC) and LEC + MCF-7 Spheroid Growth Directly and by Altering MCF-7 Secretome. | Cells | 2023 | 36766731 | PubTator, text mining | PubMed |
| Epigenetic Perspective of Immunotherapy for Cancers. | Cells | 2023 | 36766706 | PubTator, text mining | PubMed |
| The mode of action of tapasin on major histocompatibility class I (MHC-I) molecules. | J Biol Chem | 2023 | 36758805 | PubTator, text mining | PubMed |
| Increased expression of the immunoproteasome subunits PSMB8 and PSMB9 by cancer cells correlate with better outcomes for triple-negative breast cancers. | Sci Rep | 2023 | 36746983 | PubTator, text mining | PubMed |
| Editorial: The functional role of non-coding RNAs in tumor microenvironment and metastasis of genitourinary tumor and its potential application as tumor molecular biomarkers. | Front Genet | 2023 | 36741326 | PubTator, text mining | PubMed |
| Development and verification of a 7-lncRNA prognostic model based on tumor immunity for patients with ovarian cancer. | J Ovarian Res | 2023 | 36739404 | PubTator, text mining | PubMed |
| Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia. | BMC Bioinformatics | 2023 | 36737692 | PubTator, text mining | PubMed |
| A Homozygous PPP1R21 Splice Variant Associated with Severe Developmental Delay, Absence of Speech, and Muscle Weakness Leads to Activated Proteasome Function. | Mol Neurobiol | 2023 | 36692708 | PubTator, text mining | PubMed |
| Immunoproteasome inhibition prevents progression of castration-resistant prostate cancer. | Br J Cancer | 2023 | 36681728 | PubTator, text mining | PubMed |
| Review on Bortezomib Resistance in Multiple Myeloma and Potential Role of Emerging Technologies. | Pharmaceuticals (Basel) | 2023 | 36678608 | PubTator, text mining | PubMed |
| Diffuse midline glioma treated with epigenetic agent-based immunotherapy. | Signal Transduct Target Ther | 2023 | 36658142 | PubTator, text mining | PubMed |
| Clustering by antigen-presenting genes reveals immune landscapes and predicts response to checkpoint immunotherapy. | Sci Rep | 2023 | 36653470 | PubTator, text mining | PubMed |
| Identification of biomarkers and outcomes of endocrine disruption in human ovarian cortex using In Vitro Models. | Toxicology | 2023 | 36621641 | PubTator, text mining | PubMed |
| Transcriptomic analysis of the innate immune response to in vitro transfection of plasmid DNA. | Mol Ther Nucleic Acids | 2023 | 36618265 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5696/papers?page=16